BallarÃn Castán, José Aurelio;
GarcÃa López, Fernando;
Ibeas López, José;
Juárez Vela, Raúl;
Ortega Marlasca, Manuel MarÃa;
Pequeño Saco, Sandra;
Pérez Contreras, Francisco Javier;
Pérez Maraver, Manuel;
Rigau Comas, David;
Ruiz Hidalgo, Domingo;
anabria Uribe, Andrea Juliana;
Saracho Rotaeche, Ramón.
Objetivos: Esta GPC sobre Enfermedad Renal Crónica (ERC) responde a preguntas clÃnicas concernientes a su detección precoz, derivación a atención especializada y manejo, tanto mediante tratamiento farmacológico como con medidas higiénico dietéticas, estilos de vida e intervenciones educativas. As...
Insuffisance rénale chronique/diagnostic,
Insuffisance rénale chronique/thérapie,
Échographie/méthodes,
Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique,
Antihypertenseurs/usage thérapeutique,
Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique,
Approche GRADE,
Mode de vie,
Régime pauvre en sel,
Régime pauvre en protéines,
Antagonistes des récepteurs aux angiotensines/usage thérapeutique
Objetivo: Proponer recomendaciones basadas en la evidencia para el diagnóstico y tratamiento de la ERC en pacientes adultos de Colombia....
The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for all stages of chronic kidney disease (CKD) and related complications since 1997. The 2015 update of the KDOQI Clinical Practice Guideline for Hemodialysis Adequacy is intended to...
This guideline covers diagnosing, assessing, managing and monitoring anaemia in people with chronic kidney disease. It aims to improve care for people with chronic kidney disease by specifying how to assess when their anaemia needs treating, and by making detailed recommendations on treatment with erythr...
This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease....
Górriz, J. L;
Gutiérrez, F;
Trullas, J. C;
Arazo, P;
Arribas, J. R;
Barril, G;
Cervero, M;
Cofan, F;
Domingo, P;
Estrada, V;
Fulladosa, X;
Galindo, M. J;
Gracia, S;
Iribarren, J. A;
Knobel, H;
López-Aldeguer, J;
Lozano, F;
MartÃnez-Castelao, A;
MartÃnez, E;
Mazuecos, M. A;
Miralles, C;
Montañés, R;
Negredo, E;
Palacios, R;
Pérez-ElÃas, M. J;
Portilla, J;
Praga, M;
Quereda, C;
Rivero, A;
SantamarÃa, J. M;
Sanz, J;
Miró, J. M.
OBJETIVO: Actualizar las recomendaciones sobre la evaluación y el manejo de la afectación renal en pacientes con infección por el virus de la inmunodeficiencia humana (VIH). MÉTODOS: Este documento ha sido consensuado por un panel de expertos del Grupo de Estudio de Sida (GESIDA) de la Sociedad EspaÃ...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Insuffisance rénale chronique/diagnostic,
Insuffisance rénale chronique/traitement médicamenteux,
Évolution de la maladie,
Triage,
Antagonistes des récepteurs aux angiotensines/usage thérapeutique,
Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique,
Antihypertenseurs/usage thérapeutique,
Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique,
Hypolipémiants/usage thérapeutique,
Gemfibrozil/usage thérapeutique,
Maladies asymptomatiques,
Association de médicaments,
Approche GRADE
This guideline covers managing hyperphosphataemia in children, young people and adults with stage 4 or 5 chronic kidney disease. It makes recommendations on dietary management and phosphate binders, to reduce variation in care and the risk of hyperparathyroidism for people with chronic kidney disease....
